Genius Sports Surpasses Analyst Target – What’s Next for Investors?
Recently, Genius Sports Ltd (Symbol: GENI) shares traded above the average 12-month target price set by analysts at $8.95, reaching $9.47 per share. When a stock exceeds its target, analysts often have two choices: downgrade the stock based on valuation or raise their target price. Their decision can also be influenced by the company’s underlying performance, which could warrant a reassessment of forecasts.
Analyst Ratings Sketch a Mixed Picture
Within the Zacks coverage, 10 analysts have contributed to the average target for Genius Sports. However, this average represents a broad spectrum of opinions. For instance, while one analyst has set a low target at $7.00, another is optimistic with a target of $10.00, indicating a standard deviation of $0.955.
The purpose of analyzing the average price target is to leverage the collective insights, reflecting the diverse views of various analysts rather than relying on a single perspective. With GENI’s recent surge past the $8.95 target, investors are prompted to evaluate the company’s current standing. Is $8.95 merely a milestone on the path to potential highs, or has the valuation stretched too far, suggesting a time to take profits? Below is an overview of current analyst sentiment regarding Genius Sports Ltd:
Recent GENI Analyst Ratings Breakdown | ||||
---|---|---|---|---|
» | Current | 1 Month Ago | 2 Month Ago | 3 Month Ago |
Strong buy ratings: | 11 | 11 | 11 | 11 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.08 | 1.08 | 1.08 | 1.08 |
The average rating is on a scale from 1 to 5, where 1 is Strong Buy and 5 is Strong Sell. This analysis utilizes data from Zacks Investment Research via Quandl.com. For the latest research report on GENI, visit Zacks Investment Research.
10 ETFs With Most Upside To Analyst Targets »
Also see:
• MVL Videos
• Funds Holding MSVX
• BAM Options Chain
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.